Trillium Therapeutics Inc. (TRIL) Social Stream

Trillium Therapeutics Inc. (TRIL): $18.44

0.47 (+2.62%)

POWR Rating

Component Grades








Add TRIL to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals




in industry

Trillium Therapeutics Inc (TRIL) Price Targets From Analysts

Use the tables below to see what analysts covering Trillium Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
6 $21 $18.5 $19.125 $18.44 3.71%
6 $21 $18.5 $19.125 $18.44 3.71%

The Trend in the Analyst Price Target

TRIL's average price target has moved down $3.2 over the prior 26 weeks.

TRIL reports an average of 102.85% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-01 6 21 18.5 19.125 17.64 8.42%
2021-07-17 1 28 14.0 22.330 7.50 197.73%
2021-04-03 1 28 14.0 22.330 10.97 103.56%
2021-01-02 7 28 14.0 22.330 14.71 51.8%
2020-05-28 4 12 8.0 10.000 NA NA%

TRIL Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.67 1 0 5 0 0 6

The Trend in the Broker Recommendations

Over the past 61 days, TRIL's average broker recommendation rating worsened by 0.43.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The upside potential (average analyst target price relative to current price) of TRIL is greater than 4.8% of Pharmaceutical Products stocks.
  • Trillium Therapeutics Inc's variance in analysts' estimates is less than 84.3% of Pharmaceutical Products stocks.
  • The number of analysts covering the stock of TRIL is higher than 83.15% of stocks in the small market cap category.
  • Trillium Therapeutics Inc's average analyst price target is higher than 28.81% of all US stocks.

In the Pharmaceutical Products industry, QGEN, GRAY and PBH are the three stocks most similar to Trillium Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Is TRIL a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!